Policy Innovations The central address for a fairer globalization

A publication of the Carnegie Council

Text Size: A A   Print Page Mail Page Bookmark and Share
View Comments

Intellectual Property Rights and Access to Essential Medicines

By Thomas W. Pogge

October 5, 2007

From the Introduction: This essay sketches a concrete, feasible, and politically realistic plan for reforming current national and global rules so as to give the pharmaceutical industry stable and reliable financial incentives to address the severe health problems of the poor worldwide. If adopted, this plan would not add much to the overall cost of global health-care spending. In fact, on a full accounting, which would take note of the huge economic losses caused by the present global burden of disease, the reform would actually save money. Moreover, it would distribute the cost of global health-care spending more fairly across countries, across generations, and between those lucky enough to enjoy good health and the unlucky ones suffering from serious medical conditions.

External Link: Intellectual Property Rights and Access to Essential Medicines

Read More: Business, Development, Ethics, Health, Human Rights, Global

blog comments powered by Disqus

Site Search

Newsletter Signup

Please enter your email address to subscribe.

TWITTER

Follow us on Twitter.
> Go

FACEBOOK

Become a fan on Facebook.
> Go

PODCAST

Subscribe to the Carnegie Council Podcast.
> Go

RSS Feed

Subscribe to our RSS Feed.
> Go

Global Research Engine

This search includes our partner sites:

Audio / Video

08/31/10

Nic Marks

The Happy Planet Index

07/23/10

GlobalPost

Quetsol Lights Rural Guatemala

07/19/10

Ethan Zuckerman

Xenophiles Combat Imaginary Cosmopolitanism

07/12/10

Felipe Botero

MetLife Explores Microinsurance

07/08/10

Alexander Cooley, Farid Tuhbatullin

Activism in Turkmenistan